Rodrigo Toledo

Presentation(s):

• O-8: Association of MSS/MSI-RNF43 molecular subtypes and clinical outcome of metastatic BRAF-V600E colorectal cancer patients treated with anti-BRAF/EGFR ± combinatorial therapies

  Saturday, July 2, 2022
  10:50 – 11:02